Entity Details

Primary name MPI_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP34949
EntryNameMPI_HUMAN
FullNameMannose-6-phosphate isomerase
TaxID9606
Evidenceevidence at protein level
Length423
SequenceStatuscomplete
DateCreated1994-02-01
DateModified2021-06-02

Ontological Relatives

GenesMPI

GO terms

Show/Hide Table
GOName
GO:0004476 mannose-6-phosphate isomerase activity
GO:0005829 cytosol
GO:0006486 protein glycosylation
GO:0008270 zinc ion binding
GO:0009298 GDP-mannose biosynthetic process
GO:0061611 mannose to fructose-6-phosphate metabolic process
GO:0070062 extracellular exosome

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm

Domains

Show/Hide Table
DomainNameCategoryType
IPR001250 Mannose-6-phosphate isomerase, type IFamilyFamily
IPR011051 RmlC-like cupin domain superfamilyFamilyHomologous superfamily
IPR014710 RmlC-like jelly roll foldFamilyHomologous superfamily
IPR016305 Mannose-6-phosphate isomeraseFamilyFamily
IPR018050 Phosphomannose isomerase, type I, conserved siteSiteConserved site

Diseases

Show/Hide Table
Disease IDSourceNameDescription
602579 OMIMCongenital disorder of glycosylation 1B (CDG1B)A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. CDG1B is clinically characterized by protein-losing enteropathy. The disease is caused by variants affecting the gene represented in this entry.